rs886038649
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_001365276.2(TNXB):c.11650+16G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 7)
Exomes 𝑓: 0.000027 ( 0 hom. )
Consequence
TNXB
NM_001365276.2 intron
NM_001365276.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.586
Publications
0 publications found
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome due to tenascin-X deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
- familial vesicoureteral refluxInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- vesicoureteral reflux 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 6-32043421-C-T is Benign according to our data. Variant chr6-32043421-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 261116.Status of the report is criteria_provided_single_submitter, 1 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001365276.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TNXB | NM_001365276.2 | MANE Select | c.11650+16G>A | intron | N/A | NP_001352205.1 | |||
| TNXB | NM_001428335.1 | c.12391+16G>A | intron | N/A | NP_001415264.1 | ||||
| TNXB | NM_019105.8 | c.11644+16G>A | intron | N/A | NP_061978.6 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TNXB | ENST00000644971.2 | MANE Select | c.11650+16G>A | intron | N/A | ENSP00000496448.1 | |||
| TNXB | ENST00000451343.4 | TSL:1 | c.937+16G>A | intron | N/A | ENSP00000407685.1 | |||
| TNXB | ENST00000490077.5 | TSL:1 | n.1477+16G>A | intron | N/A |
Frequencies
GnomAD3 genomes Cov.: 7
GnomAD3 genomes
Cov.:
7
GnomAD2 exomes AF: 0.0000271 AC: 2AN: 73844 AF XY: 0.0000528 show subpopulations
GnomAD2 exomes
AF:
AC:
2
AN:
73844
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000274 AC: 13AN: 474522Hom.: 0 Cov.: 5 AF XY: 0.0000360 AC XY: 9AN XY: 250204 show subpopulations
GnomAD4 exome
AF:
AC:
13
AN:
474522
Hom.:
Cov.:
5
AF XY:
AC XY:
9
AN XY:
250204
show subpopulations
African (AFR)
AF:
AC:
0
AN:
13804
American (AMR)
AF:
AC:
0
AN:
26654
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
15004
East Asian (EAS)
AF:
AC:
0
AN:
31024
South Asian (SAS)
AF:
AC:
10
AN:
50020
European-Finnish (FIN)
AF:
AC:
0
AN:
29342
Middle Eastern (MID)
AF:
AC:
0
AN:
2050
European-Non Finnish (NFE)
AF:
AC:
3
AN:
279712
Other (OTH)
AF:
AC:
0
AN:
26912
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 7
GnomAD4 genome
Cov.:
7
ClinVar
ClinVar submissions as Germline
Significance:Likely benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.